Safety, Tolerability and Pharmacokinetics Study in Patients with Pulmonary Arterial Hypertension (PAH) Temporarily Switching from Oral to IV Selexipag

被引：3
|
作者：
Klose, H. [1 ]
Chin, K. [2 ]
Ewert, R. [3 ]
Gall, H. [4 ]
Parambil, J. [5 ]
Poch, D. [6 ]
Seyfarth, H. [7 ]
Axelsen, L. [8 ]
Schmitz, S. Hsu [9 ]
Stein, C. [10 ]
Preston, I. [11 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Resp Med, Ctr Oncol, Hamburg, Germany
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[3] Ernst Moritz Arndt Univ Greifswald, Dept Resp Med, Clin Internal Med, Greifswald, Germany
[4] UGMLC, Internal Med, Giessen, Germany
[5] Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Resp Inst, Cleveland, OH 44106 USA
[6] Univ Calif San Diego, Dept Pulm Crit Care, San Diego, CA 92103 USA
[7] Univ Leipzig, Dept Resp Med, Leipzig, Germany
[8] Actel Pharmaceut Ltd, Clin Pharmacol, Allschwil, Switzerland
[9] Actel Pharmaceut Ltd, Biostat, Allschwil, Switzerland
[10] Actel Pharmaceut Ltd, Clin Sci, Allschwil, Switzerland
[11] Tufts Univ, Sch Med, Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA 02111 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2019年 / 38卷 / 04期
关键词：
D O I：
10.1016/j.healun.2019.01.1247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1237
引用
收藏
页码：S490 / S490
页数：1
相关论文
共 50 条
  • [31] Selexipag real-world experience in patients over 75 yrs with pulmonary arterial hypertension (PAH)
    Gaine, Sean
    Escribano, Pilar
    Biedermann, Patricia
    Muller, Audrey
    Sun, Hong
    Soderberg, Stefan
    Lange, Tobias J.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [32] Single Center Experience In Transitioning Pulmonary Arterial Hypertension Patients From Intravenous Epoprostenol To Oral Selexipag
    Safdar, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [33] Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension: insights from a single-centre study
    Tokgoz, H. C.
    Kultursay, B.
    Tanyeri, S.
    Hakgor, A.
    Keskin, B.
    Bulus, C.
    Sekban, A.
    Sirma, D.
    Karagoz, A.
    Tanboga, I. H.
    Ozdemir, N.
    Kaymaz, C.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Safety and efficacy of sitaxsentan in elderly patients with Pulmonary Arterial Hypertension (PAH)
    Vachiery, J. L.
    Sandoval-Zarate, J.
    Keogh, A.
    Kramer, M. R.
    Barst, R. J.
    Naeije, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 623 - 623
  • [35] Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics
    White, R. James
    Parikh, Keyur
    Allen, Roblee
    Feldman, Jeremy
    Jerjez-Sanchez, Carlos
    Pan, Lei
    Keogh, Anne
    Vizza, C. Dario
    Shapiro, Shelley
    Gordon, Kathryn
    Broderick, Meredith
    Bartolome, Sonja
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [36] Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension: insights from a single-centre study
    Tokgoz, H. C.
    Kultursay, B.
    Tanyeri, S.
    Hakgor, A.
    Keskin, B.
    Bulus, C.
    Sekban, A.
    Sirma, D.
    Karagoz, A.
    Tanboga, I. H.
    Ozdemir, N.
    Kaymaz, C.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [37] Effect of selexipag on long-term outcomes in patients with pulmonary arterial hypertension (PAH) receiving one, two or no PAH therapies at baseline: results from the GRIPHON study
    Lang, I.
    Gaine, S.
    Galie, N.
    Ghofrani, H. A.
    Le Brun, F. O.
    McLaughlin, V.
    Rubin, L. J.
    Simonneau, G.
    Sitbon, O.
    Hoeper, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 381 - 382
  • [38] SELEXIPAG TITRATION AND DOSING PATTERNS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN A REAL-WORLD CLINICAL SETTING: INSIGHTS FROM THE EXPOSURE STUDY
    Johnson, M. K.
    Lange, T. J.
    Soederberg, S.
    Biedermann, P.
    Muller, A.
    Luik, K.
    Escribano, P.
    Gaine, S.
    THORAX, 2021, 76 : A50 - A51
  • [39] Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study
    Lange, T. J.
    Soderberg, S.
    Biedermann, P.
    Muller, A.
    Luik, K.
    Escribano, P.
    Gaine, S. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [40] Understanding the Pharmacokinetics of Oral Treprostinil in Patients With Pulmonary Arterial Hypertension
    Perez, Vinicio A. de Jesus
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 61 (06) : 471 - 473
12345